Management of peritonitis related to chronic ambulatory peritoneal dialysis (CAPD) using two daily intraperitoneal injections of 400 mg pefloxacin.
D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007274:Injections, Intraperitoneal; D008826:Microbial Sensitivity Tests; D015366:Pefloxacin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology
D015366:Pefloxacin